158 related articles for article (PubMed ID: 37169258)
1. Borderline Hepatocellular Adenomas: A Practical Diagnostic Approach Based on Pathologic and Molecular Features.
Poté N; Caruso S; Caderaro J; Cauchy F; Lagadec F; Couchy G; Raffenne J; Augustin J; Vernuccio F; Vilgrain V; Hercent A; Theou-Anton N; Zucman-Rossi J; Paradis V
Mod Pathol; 2023 Sep; 36(9):100211. PubMed ID: 37169258
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features.
Haefliger S; Hench J; O'Rourke CJ; Meyer-Schaller N; Uzun S; Saldarriaga J; Weber A; Mazzucchelli L; Jermann P; Frank S; Andersen JB; Terracciano L; Sempoux C; Matter MS
Histopathology; 2023 Apr; 82(5):722-730. PubMed ID: 36583256
[TBL] [Abstract][Full Text] [Related]
3. Whole-exome sequencing-based mutational profiling of hepatocellular adenoma malignant transformation to hepatocellular carcinoma.
Bu Y; Huang R; Gao J; Qu W; Fu X; Liu W; Ding Z; Zhou J; Fan J; Wang X; Chen D; Tang Z
Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13901. PubMed ID: 38843867
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas.
Chopinet S; Cauchy F; Hobeika C; Beaufrère A; Poté N; Farges O; Dokmak S; Bouattour M; Ronot M; Vilgrain V; Paradis V; Soubrane O
JHEP Rep; 2021 Aug; 3(4):100326. PubMed ID: 34368664
[TBL] [Abstract][Full Text] [Related]
5. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic characterization of hepatocellular adenomas in men: a multicenter experience.
González IA; Torbenson M; Sharifai N; Byrnes K; Chatterjee D; Kakar S; Yeh MM; Wu TT; Zhang X; Jain D
Hum Pathol; 2023 Aug; 138():24-33. PubMed ID: 37245629
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular Adenoma: Report of 2 Cases That Highlight the Relevance of Phenotype-Genotype Correlation in the Pediatric Population.
Jiao J; Finberg KE; Jain D; Morotti R
Pediatr Dev Pathol; 2023; 26(4):394-403. PubMed ID: 37334553
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
Putra J; Ferrell LD; Gouw ASH; Paradis V; Rishi A; Sempoux C; Balabaud C; Thung SN; Bioulac-Sage P
Mod Pathol; 2020 Apr; 33(4):665-675. PubMed ID: 31570768
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
[No Abstract] [Full Text] [Related]
10. Hepatocellular adenomas: review of pathological and molecular features.
Beaufrère A; Paradis V
Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
[TBL] [Abstract][Full Text] [Related]
11.
Longerich T; Endris V; Neumann O; Rempel E; Kirchner M; Abadi Z; Uhrig S; Kriegsmann M; Weiss KH; Breuhahn K; Mehrabi A; Weber TF; Wilkens L; Straub BK; Rosenwald A; Schulze F; Brors B; Froehling S; Pellegrino R; Budczies J; Schirmacher P; Stenzinger A
Gut; 2019 Jul; 68(7):1287-1296. PubMed ID: 30901310
[TBL] [Abstract][Full Text] [Related]
12. Needle tract seeding and malignant transformation of hepatocellular adenoma into well-differentiated hepatocellular carcinoma in a dog.
Jornet-Rius O; Agulla B; López MC; Viñeta C; García-Ferrer A; Serrano B; Marco A; Palomares A; Novellas R; Espada Y; Roura X; Solano-Gallego L
Vet Clin Pathol; 2023 Sep; 52(3):507-513. PubMed ID: 37202832
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular Adenoma in an Infant With Burn-McKeown Syndrome: Report of a Case.
González IA; Surrey LF; Russo P
Pediatr Dev Pathol; 2022; 25(6):668-671. PubMed ID: 36262073
[TBL] [Abstract][Full Text] [Related]
14. Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation.
Demory A; Péron JM; Calderaro J; Selves J; Mokrane FZ; Amaddeo G; Paradis V; Ziol M; Sutter O; Blaise L; Ganne-Carrié N; Vilgrain V; Cauchy F; Zucman-Rossi J; Ronot M; Nault JC
Hepatology; 2023 Feb; 77(2):430-442. PubMed ID: 35980227
[TBL] [Abstract][Full Text] [Related]
15. Hepatic adenoma: evolution of a more individualized treatment approach.
Aziz H; Underwood PW; Gosse MD; Afyouni S; Kamel I; Pawlik TM
J Gastrointest Surg; 2024 Jun; 28(6):975-982. PubMed ID: 38521190
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular neoplasms with loss of liver fatty acid binding protein: Clinicopathologic features and molecular profiling.
Joseph NM; Blank A; Shain AH; Gill RM; Umetsu SE; Shafizadeh N; Torbenson MS; Kakar S
Hum Pathol; 2022 Apr; 122():60-71. PubMed ID: 35104461
[TBL] [Abstract][Full Text] [Related]
17. Changing trends in malignant transformation of hepatocellular adenoma.
Farges O; Ferreira N; Dokmak S; Belghiti J; Bedossa P; Paradis V
Gut; 2011 Jan; 60(1):85-9. PubMed ID: 21148580
[TBL] [Abstract][Full Text] [Related]
18. Atypical Hepatocellular Neoplasms: Review of Clinical, Morphologic, Immunohistochemical, Molecular, and Cytogenetic Features.
Choi WT; Kakar S
Adv Anat Pathol; 2018 Jul; 25(4):254-262. PubMed ID: 29649004
[TBL] [Abstract][Full Text] [Related]
19. Applying criteria for hepatocellular neoplasm of uncertain malignant potential reclassifies more than half of hepatocellular adenomas.
Larson BK; Guindi M
Ann Diagn Pathol; 2021 Dec; 55():151833. PubMed ID: 34597957
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of small hepatocellular nodules in cirrhosis: surrogate histological criteria of TERT promoter mutations.
Beaufrère A; Paisley S; Ba I; Laouirem S; Priori V; Cazier H; Favre L; Cauchy F; Lesurtel M; Calderaro J; Kannengiesser C; Paradis V
Histopathology; 2024 Feb; 84(3):473-481. PubMed ID: 37903649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
